Pasquale Lombardi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

Exploration of targeted anti-tumor therapy

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Pasquale Lombardi, David James Pinato
Precision Targeting of the Gut Microbiome for Cancer Immunotherapy. Cancer discovery 14 (7) (2024)
Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Marco Filetti, Pasquale Lombardi, Valeria Altamura, Francesco Paroni Sterbini, Giovanni Scambia, Gennaro Daniele
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers. Exploration of targeted anti-tumor therapy 4 (4) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Simona Duranti, Antonella Pietragalla, Alessandra Fabi, Domenica Lorusso, Valeria Altamura, Francesco Paroni Sterbini, Giovanni Scambia, Gennaro Daniele
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years. Cancers 14 (4) (2022)
Simona Duranti, Alessandra Fabi, Marco Filetti, Rosa Falcone, Pasquale Lombardi, Gennaro Daniele, Gianluca Franceschini, Luisa Carbognin, Antonella Palazzo, Giorgia Garganese, Ida Paris, Giovanni Scambia, Antonella Pietragalla
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers 13 (20) (2021)